ReviewPharmaceuticals (Basel, Switzerland)2025

Optimizing Lenvatinib Therapy for Prognostic Improvement in Advanced Thyroid Cancer.

Tetsuro WakasugiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.